Search

Your search keyword '"Berton-Rigaud, Dominique"' showing total 271 results
Start Over Author "Berton-Rigaud, Dominique"
271 results on '"Berton-Rigaud, Dominique"'

1. The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research

Author

Moniot, Aurélie, Schneider, Christophe, Chardin, Laure, Yaniz-Galende, Elisa, Genestie, Catherine, Etiennot, Marion, Henry, Aubéri, Drelon, Coralie, Le Formal, Audrey, Langlois, Benoit, Venat, Laurence, Louvet, Christophe, Favier, Laure, Lortholary, Alain, Berton-Rigaud, Dominique, Dohollou, Nadine, Desauw, Christophe, Fabbro, Michel, Malaurie, Emmanuelle, Dubot, Coraline, Kurtz, Jean Emmanuel, Bonichon Lamichhane, Nathalie, Pujade-Lauraine, Éric, Jeanne, Albin, Leary, Alexandra, and Dedieu, Stéphane

Published
2024
Full Text
View/download PDF

2. Baseline value and longitudinal kinetics of circulating nucleosomes during neo-adjuvant chemotherapy in newly diagnosed ovarian cancer: Results from the randomized phase II trial CHIVA (GINECO).

Author

Corbaux, Pauline, primary, Colomban, Olivier, additional, Lescuyer, Gaelle, additional, Haon, Christine, additional, Ray-Coquard, Isabelle Laure, additional, De Rauglaudre, Gaetan, additional, Joly, Florence, additional, Abdeddaim, Cyril, additional, Combe, Pierre, additional, Lortholary, Alain, additional, Hamizi, Salima, additional, Deldycke, Clothilde, additional, Ferron, Gwenael, additional, Meunier, Jérôme, additional, Alexandre, Jerome, additional, Berton-Rigaud, Dominique, additional, Kaminsky, Marie-Christine, additional, Pujade-Lauraine, Eric, additional, Payen, Lea, additional, and You, Benoit, additional

Published
2024
Full Text
View/download PDF

3. Spatial profiling of ovarian carcinoma and tumor microenvironment evolution under neoadjuvant chemotherapy

Author

Yaniz-Galende, Elisa, primary, Zeng, Qinghe, additional, Grau-Bejar, Juan Francisco, additional, Klein, Christophe, additional, Blanc-Durand, Félix, additional, Le Formal, Audrey, additional, Pujade-Lauraine, Eric, additional, Chardin, Laure, additional, Edmond, Elodie, additional, Marty, Virginie, additional, Ray-Coquard, Isabelle, additional, Joly, Florence, additional, Ferron, Gwenaël, additional, Pautier, Patricia, additional, Berton-Rigaud, Dominique, additional, Lortholary, Alain, additional, Dohollou, Nadine, additional, Desauw, Christophe, additional, Fabbro, Michel, additional, Malaurie, Emmanuelle, additional, Bonichon-Lamichhane, Nathalie, additional, Bello Roufai, Diana, additional, Gantzer, Justine, additional, Rouleau, Etienne, additional, Genestie, Catherine, additional, and Leary, Alexandra, additional

Published
2024
Full Text
View/download PDF

4. Management of Rare Uterine Malignant Tumors

Author

Amant, Frederic, Hensley, Martee, Pautier, Patricia, Friedlander, Michael, Sagae, Satoru, Fujiwara, Keiichi, Berton Rigaud, Dominique, Lorusso, Domenica, Ray-Coquard, Isabelle, and Mirza, Mansoor R., editor

Published
2020
Full Text
View/download PDF

5. Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study)

Author

Robelin, Patrick, Tod, Michel, Colomban, Olivier, Lachuer, Joel, Ray-Coquard, Isabelle, Rauglaudre, Gaëtan De, Joly, Florence, Chevalier-Place, Annick, Combe, Pierre, Lortholary, Alain, Hamizi, Salima, Raban, Nadia, Ferron, Gwénaël, Meunier, Jérôme, Berton-Rigaud, Dominique, Alexandre, Jérôme, Kaminsky, Marie-Christine, Dubot, Coraline, Leary, Alexandra, Malaurie, Emmanuelle, and You, Benoit

Published
2020
Full Text
View/download PDF

6. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Author

Ackermann, Sven, Anthuber, Christoph, Aydogdu, Mustafa, Baldauf, Angelika, Bauer, Wolfgang, Behringer, Dirk, Belau, Antje, Bender, Alexandra, Brucker, Cosima, Burges, Alexander, Canzler, Ulrich, Daabach, Trygve, Denschlag, Dominik, Deryal, Mustafa, Dörfel, Steffen, Ebert, Juliane, El-Balat, Ahmed, Fehm, Tanja, Feidicker, Susanne Maria, Feisel-Schwickardi, Gabriele, Felberbaum, Ricardo, Frank, Matthias, Gebauer, Gerhard, Gerber, Bernd, Gerhardt, Axel, Grafe, Andrea, Griesshammer, Martin, Grischke, Eva-Maria, Gröll, Isolde, Gropp-Meier, Martina, Hager, Dietrich, Hanf, Volker, Hannig, Carla Verena, Hantschmann, Peer, Harter, Philipp, Hauzenberger, Tanja, Herwig, Uwe, Heubner, Martin, Hielscher, Carsten, Hilpert, Felix, Hitschold, Thomas, Hofmann, Manfred, Jackisch, Christian, Janni, Wolfgang, Kiesel, Ludwig, Ko, Yon-Dschun, Koch, Hans-Joachim, Krabisch, Petra, Krieger, Peter, Kubin, Thomas, Kühn, Thorsten, Lampe, Björn, Ledwon, Peter, Lemster, Sabine, Lex, Benno, Liebrich, Clemens, Lorenz, Ralf, Lück, Hans-Joachim, Mahner, Sven, Mallmann, Peter, Marmé, Frederik, Meier, Werner, Meinerz, Wolfgang, Menke, Götz, Möbus, Volker, Müller, Thomas, Müller, Volker, Neunhöffer, Tanja, Ober, Angelika, Oskay-Özcelik, Gülten, Ostertag, Horst, Park-Simon, Tjoung-Won, Pölcher, Martin, Rautenberg, Beate, Rein, Daniel, Reiter, Wilhelm, Rempen, Andreas, Runnebaum, Ingo, Schmalfeldt, Barbara, Schmidt, Marcus, Schnohr, Sabine, Scholz, Heinz, Schröder, Willibald, Sehouli, Jalid, Simon, Eike, Sperfeld, Antje, Steckkönig, Annette, Strauß, Hans-Georg, Stuth, Ronaldo, Terhaag, Jürgen, Thiel, Falk, Thill, Marc, Tomé, Oliver, Uleer, Christoph, Vogel, Susanne, Voß, Hermann, Weigel, Michael, Winkler, Ulrich, Wischnik, Arthur, Zeiser, Tobias, Zorr, Andreas, Glasspool, Ros, Hudson, Emma, Jones, Rachel, Lafleur, Judith, Marth, Christian, Petru, Edgar, Reinthaller, Alexander, Antill, Yoland, Azer, Mary, Baron-Hay, Sally, Beale, Philip, Begbie, Stephen, Black, Allison, Briscoe, Karen, Dean, Andrew, Goh, Jeffrey, Harvey, Sandra, Lee, Chee, Matos, Marco, Meniawy, Tarek, Olesen, Inger, Shannon, Catherine, Vasey, Paul, Abadie-Lacourtoisie, Sophie, Arsene, Olivier, Barthier, Sophie, Becuwe-Roemer, Célia, Berton-Rigaud, Dominique, Cappiello-Bataller, Maria, Catala, Stéphanie, Costan, Cristina, Del Piano, Francesco, Deplanque, Gaël, Despax, Raymond, Dohollou, Nadine, Garnier-Tixidré, Claire, Grenier, Julien, Guardiola, Emmanuel, Hardy-Bessard, Anne-Claire, Joly, Florence, Kurtz, Jean-Emmanuel, Lefeuvre-Plesse, Claudia, Leheurteur, Marianne, Lesoin, Anne, Levache, Charles-Briac, L'Haridon, Tifenn, Longo, Raffaele, Lortholary, Alain, Meunier, Jérôme, Mouret-Reynier, Marie-Ange, Petit, Thierry, Raban, Nadia, Romano, Olivier, Vannetzel, Jean-Michel, Zannetti, Alain, Pfisterer, Jacobus, Shannon, Catherine M, Baumann, Klaus, Rau, Joern, Dean, Andrew P, Hein, Alexander, Zeimet, Alain G, Hanker, Lars C, Glasspool, Rosalind, de Gregorio, Nikolaus, Meniawy, Tarek M, Goh, Jeffrey C, Baron Hay, Sally, Kommoss, Stefan, and du Bois, Andreas

Published
2020
Full Text
View/download PDF

7. “Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors”

Author

Gernier, François, Ahmed-Lecheheb, Djihane, Pautier, Patricia, Floquet, Anne, Nadeau, Cédric, Frank, Sophie, Alexandre, Jérôme, Selle, Frédéric, Berton-Rigaud, Dominique, Kalbacher, Elsa, Orfeuvre, Hubert, Lortholary, Alain, Augereau, Paule, Labombarda, Fabien, Perrier, Lionel, Grellard, Jean-Michel, Licaj, Idlir, Clarisse, Bénédicte, Savoye, Aude-Marie, Bourien, Héloise, De La Motte Rouge, Thibaut, Kurtz, Jean-Emmanuel, Kerdja, Katia, Lelaidier, Anaïs, Charreton, Amandine, Ray-Coquard, Isabelle, and Joly, Florence

Published
2021
Full Text
View/download PDF

9. Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial

Author

Romeo, Clémence, Joly, Florence, Ray-Coquard, Isabelle, El Kouri, Claude, Mercier-Blas, Anne, Berton-Rigaud, Dominique, Kalbacher, Elsa, Cojocarasu, Oana, Fabbro, Michel, Cretin, Jacques, Zannetti, Alain, Abadie-Lacourtoisie, Sophie, Mollon, Delphine, Hardy-Bessard, Anne-Claire, Provansal, Magali, Blot, Emmanuel, Delbaldo, Catherine, Lesoin, Anne, Freyer, Gilles, and You, Benoît

Published
2019
Full Text
View/download PDF

10. #208 Metabolic syndrome, long-term fatigue and inflammation in epithelial ovarian cancer survivors: vivrovaire, ancillary study

Author

Desbois, Pauline, primary, Neviere, Zoe, additional, Mauff, Brigitte Le, additional, Dauda, Mohammed Sali, additional, Gernier, François, additional, Grellard, Jean-Michel, additional, Pautier, Patricia, additional, Kalbacher, Elsa, additional, Floquet, Anne, additional, Berton-Rigaud, Dominique, additional, Abadie-Lacourtoisie, Sophie, additional, Tredan, Olivier, additional, Rousset-Jablonski, Christine, additional, Follana, Philippe, additional, Alexandre, Jerome, additional, Zanetti, Alain, additional, Dohollou, Nadine, additional, Clarisse, Benedicte, additional, Joly, Florence, additional, and Cherifi, François, additional

Published
2023
Full Text
View/download PDF

11. Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer

Author

GCIG Symptom Benefit group, King, Madeleine T., Stockler, Martin R., O'Connell, Rachel L., Buizen, Luke, Joly, Florence, Lanceley, Anne, Hilpert, Felix, Okamoto, Aikou, Aotani, Eriko, Bryce, Jane, Donnellan, Paul, Oza, Amit, Avall-Lundqvist, Elisabeth, Berek, Jonathan S., Sehouli, Jalid, Feeney, Amanda, Berton-Rigaud, Dominique, Costa, Daniel S. J., and Friedlander, Michael L.

Published
2018

13. Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)

Author

Roncolato, Felicia T., Berton-Rigaud, Dominique, O'Connell, Rachel, Lanceley, Anne, Sehouli, Jalid, Buizen, Luke, Okamoto, Aikou, Aotani, Eriko, Lorusso, Domenica, Donnellan, Paul, Oza, Amit, Avall-Lundqvist, Elisabeth, Berek, Jonathan, Hilpert, Felix, Ledermann, Jonathan A., Kaminsky, Marie Christine, Stockler, Martin R., King, Madeleine T., and Friedlander, Michael

Published
2018
Full Text
View/download PDF

14. Figure S8 from Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas

Author

Sertier, Anne-Sophie, primary, Ferrari, Anthony, primary, Pommier, Roxane M., primary, Treilleux, Isabelle, primary, Boyault, Sandrine, primary, Devouassoux-Shisheboran, Mojgan, primary, Kielbassa, Janice, primary, Thomas, Emilie, primary, Tonon, Laurie, primary, Le Texier, Vincent, primary, Charreton, Amandine, primary, Morel, Anne-Pierre, primary, Floquet, Anne, primary, Joly, Florence, primary, Berton-Rigaud, Dominique, primary, Ferron, Gwenaël, primary, Arnould, Laurent, primary, Croce, Sabrina, primary, Bataillon, Guillaume, primary, Saintigny, Pierre, primary, Mery-Lamarche, Eliane, primary, Sagan, Christine, primary, Senaratne, Aruni P., primary, Gut, Ivo G., primary, Calvo, Fabien, primary, Viari, Alain, primary, Ouzounova, Maria, primary, Ray-Coquard, Isabelle, primary, and Puisieux, Alain, primary

Published
2023
Full Text
View/download PDF

15. Supplementary Table 3 from Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas

Author

Sertier, Anne-Sophie, primary, Ferrari, Anthony, primary, Pommier, Roxane M., primary, Treilleux, Isabelle, primary, Boyault, Sandrine, primary, Devouassoux-Shisheboran, Mojgan, primary, Kielbassa, Janice, primary, Thomas, Emilie, primary, Tonon, Laurie, primary, Le Texier, Vincent, primary, Charreton, Amandine, primary, Morel, Anne-Pierre, primary, Floquet, Anne, primary, Joly, Florence, primary, Berton-Rigaud, Dominique, primary, Ferron, Gwenaël, primary, Arnould, Laurent, primary, Croce, Sabrina, primary, Bataillon, Guillaume, primary, Saintigny, Pierre, primary, Mery-Lamarche, Eliane, primary, Sagan, Christine, primary, Senaratne, Aruni P., primary, Gut, Ivo G., primary, Calvo, Fabien, primary, Viari, Alain, primary, Ouzounova, Maria, primary, Ray-Coquard, Isabelle, primary, and Puisieux, Alain, primary

Published
2023
Full Text
View/download PDF

16. FIGURE 3 from Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas

Author

Sertier, Anne-Sophie, primary, Ferrari, Anthony, primary, Pommier, Roxane M., primary, Treilleux, Isabelle, primary, Boyault, Sandrine, primary, Devouassoux-Shisheboran, Mojgan, primary, Kielbassa, Janice, primary, Thomas, Emilie, primary, Tonon, Laurie, primary, Le Texier, Vincent, primary, Charreton, Amandine, primary, Morel, Anne-Pierre, primary, Floquet, Anne, primary, Joly, Florence, primary, Berton-Rigaud, Dominique, primary, Ferron, Gwenaël, primary, Arnould, Laurent, primary, Croce, Sabrina, primary, Bataillon, Guillaume, primary, Saintigny, Pierre, primary, Mery-Lamarche, Eliane, primary, Sagan, Christine, primary, Senaratne, Aruni P., primary, Gut, Ivo G., primary, Calvo, Fabien, primary, Viari, Alain, primary, Ouzounova, Maria, primary, Ray-Coquard, Isabelle, primary, and Puisieux, Alain, primary

Published
2023
Full Text
View/download PDF

17. FIGURE 2 from Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas

Author

Sertier, Anne-Sophie, primary, Ferrari, Anthony, primary, Pommier, Roxane M., primary, Treilleux, Isabelle, primary, Boyault, Sandrine, primary, Devouassoux-Shisheboran, Mojgan, primary, Kielbassa, Janice, primary, Thomas, Emilie, primary, Tonon, Laurie, primary, Le Texier, Vincent, primary, Charreton, Amandine, primary, Morel, Anne-Pierre, primary, Floquet, Anne, primary, Joly, Florence, primary, Berton-Rigaud, Dominique, primary, Ferron, Gwenaël, primary, Arnould, Laurent, primary, Croce, Sabrina, primary, Bataillon, Guillaume, primary, Saintigny, Pierre, primary, Mery-Lamarche, Eliane, primary, Sagan, Christine, primary, Senaratne, Aruni P., primary, Gut, Ivo G., primary, Calvo, Fabien, primary, Viari, Alain, primary, Ouzounova, Maria, primary, Ray-Coquard, Isabelle, primary, and Puisieux, Alain, primary

Published
2023
Full Text
View/download PDF

18. FIGURE 4 from Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas

Author

Sertier, Anne-Sophie, primary, Ferrari, Anthony, primary, Pommier, Roxane M., primary, Treilleux, Isabelle, primary, Boyault, Sandrine, primary, Devouassoux-Shisheboran, Mojgan, primary, Kielbassa, Janice, primary, Thomas, Emilie, primary, Tonon, Laurie, primary, Le Texier, Vincent, primary, Charreton, Amandine, primary, Morel, Anne-Pierre, primary, Floquet, Anne, primary, Joly, Florence, primary, Berton-Rigaud, Dominique, primary, Ferron, Gwenaël, primary, Arnould, Laurent, primary, Croce, Sabrina, primary, Bataillon, Guillaume, primary, Saintigny, Pierre, primary, Mery-Lamarche, Eliane, primary, Sagan, Christine, primary, Senaratne, Aruni P., primary, Gut, Ivo G., primary, Calvo, Fabien, primary, Viari, Alain, primary, Ouzounova, Maria, primary, Ray-Coquard, Isabelle, primary, and Puisieux, Alain, primary

Published
2023
Full Text
View/download PDF

19. FIGURE 1 from Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas

Author

Sertier, Anne-Sophie, primary, Ferrari, Anthony, primary, Pommier, Roxane M., primary, Treilleux, Isabelle, primary, Boyault, Sandrine, primary, Devouassoux-Shisheboran, Mojgan, primary, Kielbassa, Janice, primary, Thomas, Emilie, primary, Tonon, Laurie, primary, Le Texier, Vincent, primary, Charreton, Amandine, primary, Morel, Anne-Pierre, primary, Floquet, Anne, primary, Joly, Florence, primary, Berton-Rigaud, Dominique, primary, Ferron, Gwenaël, primary, Arnould, Laurent, primary, Croce, Sabrina, primary, Bataillon, Guillaume, primary, Saintigny, Pierre, primary, Mery-Lamarche, Eliane, primary, Sagan, Christine, primary, Senaratne, Aruni P., primary, Gut, Ivo G., primary, Calvo, Fabien, primary, Viari, Alain, primary, Ouzounova, Maria, primary, Ray-Coquard, Isabelle, primary, and Puisieux, Alain, primary

Published
2023
Full Text
View/download PDF

20. Data from Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas

Author

Sertier, Anne-Sophie, primary, Ferrari, Anthony, primary, Pommier, Roxane M., primary, Treilleux, Isabelle, primary, Boyault, Sandrine, primary, Devouassoux-Shisheboran, Mojgan, primary, Kielbassa, Janice, primary, Thomas, Emilie, primary, Tonon, Laurie, primary, Le Texier, Vincent, primary, Charreton, Amandine, primary, Morel, Anne-Pierre, primary, Floquet, Anne, primary, Joly, Florence, primary, Berton-Rigaud, Dominique, primary, Ferron, Gwenaël, primary, Arnould, Laurent, primary, Croce, Sabrina, primary, Bataillon, Guillaume, primary, Saintigny, Pierre, primary, Mery-Lamarche, Eliane, primary, Sagan, Christine, primary, Senaratne, Aruni P., primary, Gut, Ivo G., primary, Calvo, Fabien, primary, Viari, Alain, primary, Ouzounova, Maria, primary, Ray-Coquard, Isabelle, primary, and Puisieux, Alain, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Table 2 from Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas

Author

Sertier, Anne-Sophie, primary, Ferrari, Anthony, primary, Pommier, Roxane M., primary, Treilleux, Isabelle, primary, Boyault, Sandrine, primary, Devouassoux-Shisheboran, Mojgan, primary, Kielbassa, Janice, primary, Thomas, Emilie, primary, Tonon, Laurie, primary, Le Texier, Vincent, primary, Charreton, Amandine, primary, Morel, Anne-Pierre, primary, Floquet, Anne, primary, Joly, Florence, primary, Berton-Rigaud, Dominique, primary, Ferron, Gwenaël, primary, Arnould, Laurent, primary, Croce, Sabrina, primary, Bataillon, Guillaume, primary, Saintigny, Pierre, primary, Mery-Lamarche, Eliane, primary, Sagan, Christine, primary, Senaratne, Aruni P., primary, Gut, Ivo G., primary, Calvo, Fabien, primary, Viari, Alain, primary, Ouzounova, Maria, primary, Ray-Coquard, Isabelle, primary, and Puisieux, Alain, primary

Published
2023
Full Text
View/download PDF

22. Supplementary Table 1 from Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas

Author

Sertier, Anne-Sophie, primary, Ferrari, Anthony, primary, Pommier, Roxane M., primary, Treilleux, Isabelle, primary, Boyault, Sandrine, primary, Devouassoux-Shisheboran, Mojgan, primary, Kielbassa, Janice, primary, Thomas, Emilie, primary, Tonon, Laurie, primary, Le Texier, Vincent, primary, Charreton, Amandine, primary, Morel, Anne-Pierre, primary, Floquet, Anne, primary, Joly, Florence, primary, Berton-Rigaud, Dominique, primary, Ferron, Gwenaël, primary, Arnould, Laurent, primary, Croce, Sabrina, primary, Bataillon, Guillaume, primary, Saintigny, Pierre, primary, Mery-Lamarche, Eliane, primary, Sagan, Christine, primary, Senaratne, Aruni P., primary, Gut, Ivo G., primary, Calvo, Fabien, primary, Viari, Alain, primary, Ouzounova, Maria, primary, Ray-Coquard, Isabelle, primary, and Puisieux, Alain, primary

Published
2023
Full Text
View/download PDF

23. Dissecting the origin of heterogeneity in uterine and ovarian carcinosarcomas

Author

Sertier, Anne-Sophie, primary, Ferrari, Anthony, additional, Pommier, Roxane M., additional, Treilleux, Isabelle, additional, Boyault, Sandrine, additional, Devouassoux-Shisheboran, Mojgan, additional, Kielbassa, Janice, additional, Thomas, Emilie, additional, Tonon, Laurie, additional, Le Texier, Vincent, additional, Charreton, Amandine, additional, Morel, Anne-Pierre, additional, Floquet, Anne, additional, Joly, Florence, additional, Berton-Rigaud, Dominique, additional, Ferron, Gwenaël, additional, Arnould, Laurent, additional, Croce, Sabrina, additional, Bataillon, Guillaume, additional, Saintigny, Pierre, additional, Mery-Lamarche, Eliane, additional, Sagan, Christine, additional, Senaratne, Aruni P., additional, Gut, Ivo G., additional, Calvo, Fabien, additional, Viari, Alain, additional, Ouzounova, Maria, additional, Ray-Coquard, Isabelle, additional, and Puisieux, Alain, additional

Published
2023
Full Text
View/download PDF

24. Management of Rare Uterine Malignant Tumors

Author

Amant, Frederic, primary, Hensley, Martee, additional, Pautier, Patricia, additional, Friedlander, Michael, additional, Sagae, Satoru, additional, Fujiwara, Keiichi, additional, Berton Rigaud, Dominique, additional, Lorusso, Domenica, additional, and Ray-Coquard, Isabelle, additional

Published
2019
Full Text
View/download PDF

25. supplementary table 2 from PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients

Author

de la Rochefordiere, Anne, primary, Kamal, Maud, primary, Floquet, Anne, primary, Thomas, Laurence, primary, Petrow, Peter, primary, Petit, Thierry, primary, Pop, Marius, primary, Fabbro, Michel, primary, Kerr, Christine, primary, Joly, Florence, primary, Sevin, Emmanuel, primary, Maillard, Sophie, primary, Curé, Hervé, primary, Weber, Béatrice, primary, Brunaud, Claire, primary, Minsat, Mathieu, primary, Gonzague, Laurence, primary, Berton-Rigaud, Dominique, primary, Aumont, Maud, primary, Gladieff, Laurence, primary, Peignaux, Karine, primary, Bernard, Virginie, primary, Leroy, Quentin, primary, Bieche, Ivan, primary, Margogne, Audrey, primary, Nadan, AnaTereza, primary, Fourchotte, Virginie, primary, Diallo, Alhassane, primary, Asselain, Benard, primary, Plancher, Corine, primary, Armanet, Sébastien, primary, Beuzeboc, Philippe, primary, and Scholl, Suzy M., primary

Published
2023
Full Text
View/download PDF

26. supplementary table 4 from PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients

Author

de la Rochefordiere, Anne, primary, Kamal, Maud, primary, Floquet, Anne, primary, Thomas, Laurence, primary, Petrow, Peter, primary, Petit, Thierry, primary, Pop, Marius, primary, Fabbro, Michel, primary, Kerr, Christine, primary, Joly, Florence, primary, Sevin, Emmanuel, primary, Maillard, Sophie, primary, Curé, Hervé, primary, Weber, Béatrice, primary, Brunaud, Claire, primary, Minsat, Mathieu, primary, Gonzague, Laurence, primary, Berton-Rigaud, Dominique, primary, Aumont, Maud, primary, Gladieff, Laurence, primary, Peignaux, Karine, primary, Bernard, Virginie, primary, Leroy, Quentin, primary, Bieche, Ivan, primary, Margogne, Audrey, primary, Nadan, AnaTereza, primary, Fourchotte, Virginie, primary, Diallo, Alhassane, primary, Asselain, Benard, primary, Plancher, Corine, primary, Armanet, Sébastien, primary, Beuzeboc, Philippe, primary, and Scholl, Suzy M., primary

Published
2023
Full Text
View/download PDF

27. supplementary table 1 from PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients

Author

de la Rochefordiere, Anne, primary, Kamal, Maud, primary, Floquet, Anne, primary, Thomas, Laurence, primary, Petrow, Peter, primary, Petit, Thierry, primary, Pop, Marius, primary, Fabbro, Michel, primary, Kerr, Christine, primary, Joly, Florence, primary, Sevin, Emmanuel, primary, Maillard, Sophie, primary, Curé, Hervé, primary, Weber, Béatrice, primary, Brunaud, Claire, primary, Minsat, Mathieu, primary, Gonzague, Laurence, primary, Berton-Rigaud, Dominique, primary, Aumont, Maud, primary, Gladieff, Laurence, primary, Peignaux, Karine, primary, Bernard, Virginie, primary, Leroy, Quentin, primary, Bieche, Ivan, primary, Margogne, Audrey, primary, Nadan, AnaTereza, primary, Fourchotte, Virginie, primary, Diallo, Alhassane, primary, Asselain, Benard, primary, Plancher, Corine, primary, Armanet, Sébastien, primary, Beuzeboc, Philippe, primary, and Scholl, Suzy M., primary

Published
2023
Full Text
View/download PDF

28. supplementary table 3 from PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients

Author

de la Rochefordiere, Anne, primary, Kamal, Maud, primary, Floquet, Anne, primary, Thomas, Laurence, primary, Petrow, Peter, primary, Petit, Thierry, primary, Pop, Marius, primary, Fabbro, Michel, primary, Kerr, Christine, primary, Joly, Florence, primary, Sevin, Emmanuel, primary, Maillard, Sophie, primary, Curé, Hervé, primary, Weber, Béatrice, primary, Brunaud, Claire, primary, Minsat, Mathieu, primary, Gonzague, Laurence, primary, Berton-Rigaud, Dominique, primary, Aumont, Maud, primary, Gladieff, Laurence, primary, Peignaux, Karine, primary, Bernard, Virginie, primary, Leroy, Quentin, primary, Bieche, Ivan, primary, Margogne, Audrey, primary, Nadan, AnaTereza, primary, Fourchotte, Virginie, primary, Diallo, Alhassane, primary, Asselain, Benard, primary, Plancher, Corine, primary, Armanet, Sébastien, primary, Beuzeboc, Philippe, primary, and Scholl, Suzy M., primary

Published
2023
Full Text
View/download PDF

29. Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer

Author

King, Madeleine T., Stockler, Martin R., O’Connell, Rachel L., Buizen, Luke, Joly, Florence, Lanceley, Anne, Hilpert, Felix, Okamoto, Aikou, Aotani, Eriko, Bryce, Jane, Donnellan, Paul, Oza, Amit, Avall-Lundqvist, Elisabeth, Berek, Jonathan S., Sehouli, Jalid, Feeney, Amanda, Berton-Rigaud, Dominique, Costa, Daniel S. J., Friedlander, Michael L., and for the GCIG Symptom Benefit group

Published
2017
Full Text
View/download PDF

30. BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study

Author

Harter, Philipp, Johnson, Toby, Berton-Rigaud, Dominique, Park, Sang-Yoon, Friedlander, Michael, del Campo, Josep M., Shimada, Muneaki, Forget, Frédéric, Mirza, Mansoor R., Colombo, Nicoletta, Zamagni, Claudio, Chan, John K., Imhof, Martin, Herzog, Thomas J., O'Donnell, Dearbhaile, Heitz, Florian, King, Karen, Stinnett, Sandy, Barrett, Catherine, Jobanputra, Minesh, Xu, Chun-Fang, and du Bois, Andreas

Published
2016
Full Text
View/download PDF

31. Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer

Author

Lorusso, Domenica, Hilpert, Felix, González Martin, Antonio, Rau, Joern, Ottevanger, Petronella, Greimel, Elfriede, Lück, Hans-Joachim, Selle, Frédéric, Colombo, Nicoletta, Kroep, Judith R, Mirza, Mansoor R, Berger, Regina, Pardo, Beatriz, Grischke, Eva-Maria, Berton-Rigaud, Dominique, Martinez-Garcia, Jeronimo, Vergote, Ignace, Redondo, Andrés, Cardona, Andrés, Bastière-Truchot, Lydie, du Bois, Andreas, and Kurzeder, Christian

Published
2019
Full Text
View/download PDF

34. Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network

Author

Bonsang-Kitzis, Hélène, primary, Panchbhaya, Nabilah, additional, Bats, Anne-Sophie, additional, Pujade-Lauraine, Eric, additional, Pautier, Patricia, additional, Ngô, Charlotte, additional, Le Frère-Belda, Marie-Aude, additional, Kalbacher, Elsa, additional, Floquet, Anne, additional, Berton-Rigaud, Dominique, additional, Lefeuvre-Plesse, Claudia, additional, Fabbro, Michel, additional, Ray-Coquard, Isabelle, additional, and Lécuru, Fabrice, additional

Published
2022
Full Text
View/download PDF

36. Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study

Author

Sehouli, Jalid, Pietzner, Klaus, Wimberger, Pauline, Vergote, Ignace, Rosenberg, Per, Schneeweiss, Andreas, Bokemeyer, Carsten, Salat, Christoph, Scambia, Giovanni, Berton-Rigaud, Dominique, Santoro, Armando, Cervantes, Andrés, Trédan, Olivier, Tournigand, Christophe, Colombo, Nicoletta, Dudnichenko, Alexander S., Westermann, Anneke, Friccius-Quecke, Hilke, and Lordick, Florian

Published
2014
Full Text
View/download PDF

38. 268 A phase 1 study of retifanlimab (INCMGA00012), a PD-1 inhibitor, in patients with advanced solid tumors: preliminary results in recurrent MSI-high or dMMR endometrial cancer (POD1UM-101)

Author

Berton-Rigaud, Dominique, primary, Vergote, Ignace, additional, Pautier, Patricia, additional, Kryzhanivska, Anna, additional, Angelergues, Antoine, additional, Kornacki, Deanna, additional, Dudzisz-Sledz, Monika, additional, Tian, Chuan, additional, Bourayou, Nawel, additional, and Selle, Frederic, additional

Published
2020
Full Text
View/download PDF

41. Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Author

Pfisterer, Jacobus, primary, Shannon, Catherine M, additional, Baumann, Klaus, additional, Rau, Joern, additional, Harter, Philipp, additional, Joly, Florence, additional, Sehouli, Jalid, additional, Canzler, Ulrich, additional, Schmalfeldt, Barbara, additional, Dean, Andrew P, additional, Hein, Alexander, additional, Zeimet, Alain G, additional, Hanker, Lars C, additional, Petit, Thierry, additional, Marmé, Frederik, additional, El-Balat, Ahmed, additional, Glasspool, Rosalind, additional, de Gregorio, Nikolaus, additional, Mahner, Sven, additional, Meniawy, Tarek M, additional, Park-Simon, Tjoung-Won, additional, Mouret-Reynier, Marie-Ange, additional, Costan, Cristina, additional, Meier, Werner, additional, Reinthaller, Alexander, additional, Goh, Jeffrey C, additional, L'Haridon, Tifenn, additional, Baron Hay, Sally, additional, Kommoss, Stefan, additional, du Bois, Andreas, additional, Kurtz, Jean-Emmanuel, additional, Ackermann, Sven, additional, Anthuber, Christoph, additional, Aydogdu, Mustafa, additional, Baldauf, Angelika, additional, Bauer, Wolfgang, additional, Behringer, Dirk, additional, Belau, Antje, additional, Bender, Alexandra, additional, Brucker, Cosima, additional, Burges, Alexander, additional, Daabach, Trygve, additional, Denschlag, Dominik, additional, Deryal, Mustafa, additional, Dörfel, Steffen, additional, Ebert, Juliane, additional, Fehm, Tanja, additional, Feidicker, Susanne Maria, additional, Feisel-Schwickardi, Gabriele, additional, Felberbaum, Ricardo, additional, Frank, Matthias, additional, Gebauer, Gerhard, additional, Gerber, Bernd, additional, Gerhardt, Axel, additional, Grafe, Andrea, additional, Griesshammer, Martin, additional, Grischke, Eva-Maria, additional, Gröll, Isolde, additional, Gropp-Meier, Martina, additional, Hager, Dietrich, additional, Hanf, Volker, additional, Hannig, Carla Verena, additional, Hantschmann, Peer, additional, Hauzenberger, Tanja, additional, Herwig, Uwe, additional, Heubner, Martin, additional, Hielscher, Carsten, additional, Hilpert, Felix, additional, Hitschold, Thomas, additional, Hofmann, Manfred, additional, Jackisch, Christian, additional, Janni, Wolfgang, additional, Kiesel, Ludwig, additional, Ko, Yon-Dschun, additional, Koch, Hans-Joachim, additional, Krabisch, Petra, additional, Krieger, Peter, additional, Kubin, Thomas, additional, Kühn, Thorsten, additional, Lampe, Björn, additional, Ledwon, Peter, additional, Lemster, Sabine, additional, Lex, Benno, additional, Liebrich, Clemens, additional, Lorenz, Ralf, additional, Lück, Hans-Joachim, additional, Mallmann, Peter, additional, Meinerz, Wolfgang, additional, Menke, Götz, additional, Möbus, Volker, additional, Müller, Thomas, additional, Müller, Volker, additional, Neunhöffer, Tanja, additional, Ober, Angelika, additional, Oskay-Özcelik, Gülten, additional, Ostertag, Horst, additional, Pölcher, Martin, additional, Rautenberg, Beate, additional, Rein, Daniel, additional, Reiter, Wilhelm, additional, Rempen, Andreas, additional, Runnebaum, Ingo, additional, Schmidt, Marcus, additional, Schnohr, Sabine, additional, Scholz, Heinz, additional, Schröder, Willibald, additional, Simon, Eike, additional, Sperfeld, Antje, additional, Steckkönig, Annette, additional, Strauß, Hans-Georg, additional, Stuth, Ronaldo, additional, Terhaag, Jürgen, additional, Thiel, Falk, additional, Thill, Marc, additional, Tomé, Oliver, additional, Uleer, Christoph, additional, Vogel, Susanne, additional, Voß, Hermann, additional, Weigel, Michael, additional, Winkler, Ulrich, additional, Wischnik, Arthur, additional, Zeiser, Tobias, additional, Zorr, Andreas, additional, Glasspool, Ros, additional, Hudson, Emma, additional, Jones, Rachel, additional, Lafleur, Judith, additional, Marth, Christian, additional, Petru, Edgar, additional, Antill, Yoland, additional, Azer, Mary, additional, Baron-Hay, Sally, additional, Beale, Philip, additional, Begbie, Stephen, additional, Black, Allison, additional, Briscoe, Karen, additional, Dean, Andrew, additional, Goh, Jeffrey, additional, Harvey, Sandra, additional, Lee, Chee, additional, Matos, Marco, additional, Meniawy, Tarek, additional, Olesen, Inger, additional, Shannon, Catherine, additional, Vasey, Paul, additional, Abadie-Lacourtoisie, Sophie, additional, Arsene, Olivier, additional, Barthier, Sophie, additional, Becuwe-Roemer, Célia, additional, Berton-Rigaud, Dominique, additional, Cappiello-Bataller, Maria, additional, Catala, Stéphanie, additional, Del Piano, Francesco, additional, Deplanque, Gaël, additional, Despax, Raymond, additional, Dohollou, Nadine, additional, Garnier-Tixidré, Claire, additional, Grenier, Julien, additional, Guardiola, Emmanuel, additional, Hardy-Bessard, Anne-Claire, additional, Lefeuvre-Plesse, Claudia, additional, Leheurteur, Marianne, additional, Lesoin, Anne, additional, Levache, Charles-Briac, additional, Longo, Raffaele, additional, Lortholary, Alain, additional, Meunier, Jérôme, additional, Raban, Nadia, additional, Romano, Olivier, additional, Vannetzel, Jean-Michel, additional, and Zannetti, Alain, additional

Published
2020
Full Text
View/download PDF

42. Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [18F]Fluorodeoxyglucose Positron Emission Tomography

Author

Rousseau, Caroline, Devillers, Anne, Sagan, Christine, Ferrer, Ludovic, Bridji, Boumédiène, Campion, Loïc, Ricaud, Myriam, Bourbouloux, Emmanuelle, Doutriaux, Isabelle, Clouet, Martine, Berton-Rigaud, Dominique, Bouriel, Catherine, Delecroix, Valérie, Garin, Etienne, Rouquette, Sophie, Resche, Isabelle, Kerbrat, Pierre, Chatal, Jean François, and Campone, Mario

Published
2006
Full Text
View/download PDF

43. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: Results of the French Adjuvant Study Group

Author

Benchalal, Mohamed, Le Prisé, Elisabeth, de Lafontan, Brigitte, Berton-Rigaud, Dominique, Belkacemi, Yazid, Romestaing, Pascale, Peignaux, Karine, Courdi, Adel, Monnier, Alain, Montcuquet, Philippe, Goudier, Marie-Josèphe, Marchal, Christian, Chollet, Philippe, Abadie-Lacourtoisie, Sophie, Datchary, Jean, Veyret, Corinne, and Kerbrat, Pierre

Published
2005
Full Text
View/download PDF

44. Pertuzumab for the treatment of breast cancer

Author

Robert, Marie, primary, Frenel, Jean-Sébastien, additional, Bourbouloux, Emmanuelle, additional, Berton Rigaud, Dominique, additional, Patsouris, Anne, additional, Augereau, Paule, additional, Gourmelon, Carole, additional, and Campone, Mario, additional

Published
2019
Full Text
View/download PDF

45. Pooled analysis of onapristone extended release (ONA ER) in metastatic cancer patients (pts): A review of liver safety.

Author

Cottu, Paul H., primary, Jayaram, Anuradha, additional, Italiano, Antoine, additional, Pacey, Simon, additional, Leary, Alexandra, additional, Jones, Robert J, additional, Campone, Mario, additional, Floquet, Anne, additional, Berton Rigaud, Dominique, additional, Lhomme, Catherine, additional, Sablin, Marie-Paule, additional, Bexon, Alice Susannah, additional, Bonneterre, Jacques, additional, Attard, Gerhardt, additional, and Watkins, Paul B, additional

Published
2019
Full Text
View/download PDF

46. Menopausal symptoms in epithelial ovarian cancer survivors: The GINECO VIVROVAIRE2 study.

Author

Joly, Florence, primary, Pautier, Patricia, additional, Kalbacher, Elsa, additional, Gernier, François, additional, Fauvet, Raffaele, additional, Floquet, Anne, additional, Berton-Rigaud, Dominique, additional, Tredan, Olivier, additional, Follana, Philippe, additional, Alexandre, Jerome, additional, Zannetti, Alain, additional, Dohollou, Nadine, additional, Trager, Stephanie, additional, Licaj, Idlir, additional, Grellard, Jean-Michel, additional, Clarisse, Bénédicte, additional, Ahmed-Lecheheb, Djihane, additional, Rousset-Jablonski, Christine, additional, and Gompel, Anne, additional

Published
2019
Full Text
View/download PDF

48. Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers

Author

Cottu, Paul H., primary, Bonneterre, Jacques, additional, Varga, Andrea, additional, Campone, Mario, additional, Leary, Alexandra, additional, Floquet, Anne, additional, Berton-Rigaud, Dominique, additional, Sablin, Marie-Paule, additional, Lesoin, Anne, additional, Rezai, Keyvan, additional, Lokiec, François M., additional, Lhomme, Catherine, additional, Bosq, Jacques, additional, Bexon, Alice S., additional, Gilles, Erard M., additional, Proniuk, Stefan, additional, Dieras, Veronique, additional, Jackson, David M., additional, Zukiwski, Alexander, additional, and Italiano, Antoine, additional

Published
2018
Full Text
View/download PDF

49. Pertuzumab for the treatment of breast cancer.

Author

Robert, Marie, Frenel, Jean-Sébastien, Bourbouloux, Emmanuelle, Berton Rigaud, Dominique, Patsouris, Anne, Augereau, Paule, Gourmelon, Carole, and Campone, Mario

Subjects
BREAST cancer, EPIDERMAL growth factor receptors, METASTATIC breast cancer, CANCER treatment, MONOCLONAL antibodies, CELL receptors, COMBINED modality therapy, BREAST tumors, DRUG resistance in cancer cells
Abstract

Introduction: Pertuzumab, a humanized monoclonal antibody that binds the human epidermal growth factor receptor 2 (HER2), inhibits the heterodimerization of HER2 with other HER receptors. It has been approved both by the Food and Drug Administration and the European Medicine Agency in the metastatic, neoadjuvant and adjuvant setting.Areas covered: This review analyses and discusses preclinical and clinical studies of pertuzumab in breast cancer. In this article, we review the status of pertuzumab, the completed and ongoing trials, and its safety.Expert opinion: Pertuzumab is a key drug for the treatment of HER2-positive metastatic or early breast cancer. However, it is imperative to identify patients that will need dual-targeting and mechanisms of resistance. Moreover, the value of pertuzumab beyond progression needs to be evaluated. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

50. Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

Author

Oza, Amit M, primary, Matulonis, Ursula A, additional, Malander, Susanne, additional, Hudgens, Stacie, additional, Sehouli, Jalid, additional, del Campo, Josep M, additional, Berton-Rigaud, Dominique, additional, Banerjee, Susana, additional, Scambia, Giovanni, additional, Berek, Jonathan S, additional, Lund, Bente, additional, Tinker, Anna V, additional, Hilpert, Felix, additional, Vázquez, Isabel Palacio, additional, D'Hondt, Véronique, additional, Benigno, Benedict, additional, Provencher, Diane, additional, Buscema, Joseph, additional, Agarwal, Shefali, additional, and Mirza, Mansoor R, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results